Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124908193 | 12490819 | 3 | F | 201602 | 20160712 | 20160622 | 20160718 | EXP | JP-ROCHE-1780533 | ROCHE | HASEGAWA J. . ;:-. | 51.00 | YR | F | Y | 0.00000 | 20160718 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124908193 | 12490819 | 1 | PS | AVASTIN | BEVACIZUMAB | 1 | Intravenous drip | . | U | 125085 | SOLUTION FOR INFUSION | ||||||||
| 124908193 | 12490819 | 2 | SS | AVASTIN | BEVACIZUMAB | 1 | Intravenous drip | DOSAGE IS UNCERTAIN. | U | 125085 | |||||||||
| 124908193 | 12490819 | 3 | SS | AVASTIN | BEVACIZUMAB | 1 | Intravenous drip | DOSAGE IS UNCERTAIN. | U | 125085 | |||||||||
| 124908193 | 12490819 | 4 | SS | TIPIRACIL HYDROCHLORIDE/TRIFLURIDINE | TIPIRACIL HYDROCHLORIDETRIFLURIDINE | 1 | Unknown | DOSAGE IS UNCERTAIN. | U | 0 | |||||||||
| 124908193 | 12490819 | 5 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous drip | DOSAGE IS UNCERTAIN. | U | 0 | |||||||||
| 124908193 | 12490819 | 6 | C | XELODA | CAPECITABINE | 1 | Oral | DOSAGE IS UNCERTAIN. | 0 | TABLET | |||||||||
| 124908193 | 12490819 | 7 | C | IRINOTECAN HYDROCHLORIDE. | IRINOTECAN HYDROCHLORIDE | 1 | Intravenous drip | DOSAGE IS UNCERTAIN. | 0 | ||||||||||
| 124908193 | 12490819 | 8 | C | IRINOTECAN HYDROCHLORIDE. | IRINOTECAN HYDROCHLORIDE | 1 | Intravenous drip | DOSAGE IS UNCERTAIN. | 0 | ||||||||||
| 124908193 | 12490819 | 9 | C | PANITUMUMAB | PANITUMUMAB | 1 | Unknown | DOSAGE IS UNCERTAIN. | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124908193 | 12490819 | 1 | Colon cancer |
| 124908193 | 12490819 | 2 | Colon cancer |
| 124908193 | 12490819 | 3 | Colon cancer |
| 124908193 | 12490819 | 4 | Product used for unknown indication |
| 124908193 | 12490819 | 5 | Colon cancer |
| 124908193 | 12490819 | 6 | Colon cancer |
| 124908193 | 12490819 | 7 | Colon cancer |
| 124908193 | 12490819 | 8 | Colon cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124908193 | 12490819 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124908193 | 12490819 | Neutropenia | |
| 124908193 | 12490819 | Shock |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |